Next |
home / stock / rytm / rytm message board
Subject | By | Source | When |
---|---|---|---|
$RYTM what do you make of this data? | grich1 | investorshub | 04/27/2023 2:46:30 AM |
Do we have a winner?Turn around time? | Amatuer17 | investorshub | 04/19/2023 9:26:37 PM |
should we be shorting? | midastouch017 | investorshub | 04/17/2023 6:06:09 PM |
$RYTM The gaining up | Amatuer17 | investorshub | 04/16/2023 9:29:03 PM |
$RYTM MomentumIts trading up | bandit007 | investorshub | 04/15/2023 1:05:19 PM |
$RYTM The trading | pennyrich | investorshub | 04/14/2023 9:43:56 AM |
$RYTM When is this gonna take off? | Amatuer17 | investorshub | 04/14/2023 7:09:31 AM |
short squeeze article | Laszlo1 | investorshub | 04/13/2023 1:50:31 AM |
MomentumIts trading | Amatuer17 | investorshub | 04/12/2023 9:34:58 PM |
$RYTM The trading | midastouch017 | investorshub | 04/10/2023 6:13:57 AM |
$RYTM Price now | midastouch017 | investorshub | 04/06/2023 10:42:00 PM |
$RYTM bulls and bears | Amatuer17 | investorshub | 04/06/2023 2:03:44 PM |
MomentumIts now | Amatuer17 | investorshub | 04/04/2023 7:41:22 PM |
$RYTM MomentumIts now last trade up | midastouch017 | investorshub | 04/04/2023 7:23:50 PM |
In my view $ORMP is better than RYTM | midastouch017 | investorshub | 01/23/2023 4:28:26 PM |
znewcar1: f55,720M HOD24.6 got lead in the PPS | znewcar1 | investorshangout | 09/28/2022 5:17:28 PM |
znewcar1: Getting a few hits! needs vol >2.5M/d only v320K | znewcar1 | investorshangout | 09/28/2022 4:11:16 PM |
znewcar1: $RYTM HOD24.55 R25.5, 28+31 & #MOON HH43.26 last year what a turnaround! | znewcar1 | investorshangout | 09/28/2022 4:04:58 PM |
znewcar1: RYTM 24% V2,3m C30.85 F50,7m h30.98 ml20.11 | znewcar1 | investorshangout | 09/14/2022 10:14:05 PM |
znewcar1: RYTM 21% v2,0M c26.45 f50,7M H27.29 ML8.06 | znewcar1 | investorshangout | 08/16/2022 1:24:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Rhythm Pharmaceuticals Inc. Company Name:
RYTM Stock Symbol:
NASDAQ Market:
Rhythm Pharmaceuticals Inc. Website:
-- First quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $26.0 million -- -- On track to submit sNDA to the FDA to...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
-- First quarter 2024 net revenue from global sales of IMCIVREE ® (setmelanotide) of $26.0 million -- -- On track to submit sNDA to the FDA to treat pediatric patients between 2 and younger than 6 years old in approved indications in second quarter of 2024 -- --...